Wire · opportunities
NZ biotech start-up Daisy Lab's expansion hopes after UK acquisition
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 16 October 2026 · Fusion42 review
New Zealand biotech start-up Daisy Lab, which produces animal-free dairy proteins via precision fermentation, has been acquired by UK-based Mycofeast, facilitating its global expansion and large-scale production in Europe. The acquisition aligns with increased regulatory approval to scale fermentation production and connects Daisy Lab with broader industrial biotechnology capabilities.
This Wire brief sits within Fusion42's coverage of Foodtech.
◆ ◆ The Wire takeaway
You now have a route to scale animal-free dairy protein production beyond New Zealand through established industrial fermentation networks in Europe. This opens doors for rare ingredient makers to bypass local scale limits by linking with global biomanufacturing partners.
◆ Coverage
1 source · 16 Oct 2026
◆ Related on Wire
◆ Topics